Enzyme Replacement Therapy Medicines

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-r6ebe6-0000774980-2024-08-15T00:00:00Z",
    "date": "2024-08-15T00:00:00Z",
    "ocid": "ocds-r6ebe6-0000774980",
    "initiationType": "tender",
    "parties": [
        {
            "id": "org-195",
            "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
            "identifier": {
                "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
            },
            "address": {
                "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
                "locality": "Edinburgh",
                "postalCode": "EH12 9EB"
            },
            "contactPoint": {
                "url": "http://"
            },
            "roles": [
                "reviewBody",
                "buyer"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ]
            }
        },
        {
            "id": "org-305",
            "name": "Takeda UK Limited",
            "identifier": {
                "legalName": "Takeda UK Limited"
            },
            "address": {
                "streetAddress": "1 Kingdom Street",
                "locality": "London",
                "region": "UKM",
                "postalCode": "W2 6BD"
            },
            "contactPoint": {
                "telephone": "+44 7500578049"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "sme",
                "url": "http://"
            }
        },
        {
            "id": "org-5",
            "name": "Sheriff Court House",
            "identifier": {
                "legalName": "Sheriff Court House"
            },
            "address": {
                "streetAddress": "27 Chambers Street",
                "locality": "Edinburgh",
                "postalCode": "EH1 1LB"
            },
            "contactPoint": {
                "email": "nssprocurementteam@nhs.scot",
                "url": "http://"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
        "id": "org-195"
    },
    "tender": {
        "id": "ocds-r6ebe6-0000774980",
        "title": "Enzyme Replacement Therapy Medicines",
        "description": "Supply of Enzyme Replacement Therapy Medicines (e-g) to NHS Scotland: - NP92624(e) Velaglucerase alfa 400units powder for solution for infusion vials 1 vial (VPRIV(r)) - NP92624(f) Idursulfase 6mg/3ml solution for infusion vials 1 vial (Elaprase(r)) - NP92624(g) Agalsidase alfa 3.5mg/3.5ml solution for infusion vials 1 vial (Replagal(r))",
        "status": "complete",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "id": "33600000",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "procurementMethodRationale": "The medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.",
        "mainProcurementCategory": "goods",
        "documents": [
            {
                "id": "AUG512134",
                "documentType": "awardNotice",
                "title": "Enzyme Replacement Therapy Medicines",
                "description": "Supply of Enzyme Replacement Therapy Medicines (e-g) to NHS Scotland: - NP92624(e) Velaglucerase alfa 400units powder for solution for infusion vials 1 vial (VPRIV(r)) - NP92624(f) Idursulfase 6mg/3ml solution for infusion vials 1 vial (Elaprase(r)) - NP92624(g) Agalsidase alfa 3.5mg/3.5ml solution for infusion vials 1 vial (Replagal(r))",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG512134",
                "format": "text/html"
            }
        ],
        "lots": [
            {
                "id": "1",
                "description": "The Framework Agreement is for the supply of Enzyme Replacement Therapy Medicines (e-g: VPRIV(r)/ Elaprase(r)/ Replagal(r)) to NHS Scotland. The Authority has awarded this framework as a Single supplier framework agreement to one (1) Framework Participant.",
                "status": "complete",
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price"
                        }
                    ]
                },
                "hasOptions": false
            }
        ],
        "coveredBy": [
            "GPA"
        ],
        "procurementMethodRationaleClassifications": [
            {
                "id": "D_PROTECT_RIGHTS",
                "description": "The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights",
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
            }
        ],
        "techniques": {
            "hasFrameworkAgreement": true
        },
        "classification": {
            "id": "33600000",
            "scheme": "CPV"
        },
        "reviewDetails": "Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts: An economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session. The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        }
    },
    "awards": [
        {
            "id": "NP92624 (e-g)",
            "suppliers": [
                {
                    "id": "org-305",
                    "name": "Takeda UK Limited"
                }
            ],
            "relatedLots": [
                "1"
            ]
        }
    ],
    "contracts": [
        {
            "id": "NP92624 (e-g)",
            "awardID": "NP92624 (e-g)",
            "status": "active",
            "value": {
                "amount": 6079596,
                "currency": "GBP"
            },
            "dateSigned": "2024-07-19T00:00:00Z"
        }
    ],
    "language": "EN",
    "relatedProcesses": [
        {
            "id": "1",
            "relationship": [
                "planning"
            ],
            "scheme": "EU-OJ",
            "identifier": "2024/S 000-020106"
        }
    ],
    "description": "The estimated value(s) of the Framework Agreement referred to in Sections II.1.7 and V.2.4 cover(s) the twenty-four (24) month contract duration and the twelve (12) month extension period of the Framework Agreement. (SC Ref:774980)",
    "bids": {
        "statistics": [
            {
                "id": "465",
                "measure": "bids",
                "value": 1,
                "relatedLot": "1"
            },
            {
                "id": "466",
                "measure": "smeBids",
                "value": 1,
                "relatedLot": "1"
            },
            {
                "id": "467",
                "measure": "foreignBidsFromEU",
                "value": 0,
                "relatedLot": "1"
            },
            {
                "id": "468",
                "measure": "foreignBidsFromNonEU",
                "value": 1,
                "relatedLot": "1"
            },
            {
                "id": "469",
                "measure": "electronicBids",
                "value": 1,
                "relatedLot": "1"
            }
        ]
    },
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000774980"
        }
    ],
    "noticetype": "OJEU - F3 - Contract Award Notice"
}